Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain

AIDS Research and Human Retroviruses

Volumn 25, Issue 6, 2009, Pages 551-554

  Treviño, Ana ^a   Aguilera, Antonio ^b   Caballero, Estrella ^c   Toro, Carlos ^a   Eiros, José M ^d   De Lejarazu, Raúl Ortiz ^d   Rodríguez Calviño, Juan J ^b   Tuset, Concepción ^e   Gómez Hernando, César ^f   Rodríguez Iglesias, Manuel ^g   Ramos, José Manuel ^h   Rodríguez Díaz, Juan C ⁱ   Benito, Rafael ^j   Trigo, Matilde ^k   García Campello, Marta ^k   Calderón, Enrique ^l   Garcia, Juan ^m   Rodríguez, Carmen ⁿ   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL DE CONXO   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f HOSPITAL VIRGEN DE LA SALUD   (Spain)

^g HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^h Hospital General   (Spain)

ⁱ Hospital General Universitario   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^k Servicio de Medicina Interna Enfermedades Infecciosas   (Spain)

^l HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^m Hospital Cristal Pinor   (Spain)

ⁿ CENTRO SANITARIO SANDOVAL   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; VIRUS ANTIBODY;

ADULT; AFRICA; ARTICLE; BOLIVIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; FEMALE; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMIGRANT; MAJOR CLINICAL STUDY; MASS SCREENING; OUTPATIENT DEPARTMENT; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; SEROPREVALENCE; SOUTH AMERICA; SPAIN; WESTERN BLOTTING; BLOOD; EPIDEMIOLOGY; ETHNIC AND RACIAL GROUPS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MIGRATION; PREGNANCY;

ADULT; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION; POPULATION GROUPS; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES; SPAIN; YOUNG ADULT;

EID: 67651160453     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0268     Document Type: Article

References (18)

1. Madeleine M, Wiktor S, Goedert J, et al.: HTLV-I and HTLV-II worldwide distribution: Reanalysis of 4,832 immunoblot results. Int J Cancer 1993;54:255-260.
2. Manns A, Hisada M, and La Grenade L: Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-1958.
3. Roucoux D, and Murphy E: The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004;6:144-154.
4. Proietti F, Carneiro-Proietti A, Catalan-Soares B, et al.: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058-6068.
5. Tsuji Y, Doi H, Yamabe T, et al.: Prevention of mother-to-child transmission of human T lymphotropic virus type 1. Pediatrics 1990;86:11-17.
6. Andersson S, Gessain A, and Taylor G: Pooling of samples for seroepidemiological surveillance of human T-cell lym-photropic virus (HTLV) types I and II. Virus Res 2001;78: 101-106.
7. HTLV European Research Network: Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:68-77.
8. Toro C, Rodés B, Bassani S, et al.: Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain. J Clin Virol 2005;33:65-70.
9. Miura T, Yamashita M, Zaninovic V, et al.: Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile. J Mol Evol 1997; 44(Suppl 1):76-82.
10. Taylor G, Bodéus M, Courtois F, et al.: The seroepidemiology of human T-lymphotropic viruses: Types I and II in Europe: A prospective study of pregnant women. J Acquir Immune Defic Syndr 2005;38:104-109.
11. Laperche S, Worms B, Pillonel J, et al.: Blood safety strategies for HTLCV in Europe. Vox Sang 2009;96:104-110.
12. Hino S, Katamine S, Miyata H, et al.: Primary prevention of HTLV-I in Japan. J Acquir Immune Defic Syndr Hum Ret-rovirol 1996;13(Suppl 1):199-203.
13. Ades A, Parker S, Walker J, et al.: Human T cell leukaemia/ lymphoma virus infection in pregnant women in the United Kingdom: Population study. BMJ 2000;320:1497-1501.
14. Toro C, Soriano V, on behalf of the Spanish HTLV & HIV-2 Study Group: Update on HIV-2 and HTLV-1/2 infections in Spain. Enf Infecc Microbiol Clin (in press).
15. Fuente L, Toro C, Soriano V, Brugal M, Vallejo F, Barrio G, et al.: HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates. J Clin Virol 2006;35:244-249.
16. Machuca A, Tuset C, Soriano V, et al.: Prevalence of HTLV infection in pregnant women in Spain. Sex Transm Infect 2000;76:366-370.
17. Bravo MJ, Royuela L, Barrio G, de la Fuente L, Suarez M, and Brugal MT: More free syringes, fewer drug injectors in the case of Spain. Soc Sci Med 2007;65:1773-1778.
18. Casoli C, Pilotti E, and Bertazzoni U: Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev 2007;9:140-149.